COVID-19 Vaccine Update, September 24: Johnson & Johnson candidate enters phase-3 trials
September 24, 2020 5:33 pm
Coronavirus (COVID-19) vaccine update, September 24: The candidate vaccines of AstraZeneca-Oxford, Pfizer and Moderna are already undergoing phase-3 trials in the US. The Johnson & Johnson vaccine could potentially be a single-shot vaccine.
No hay comentarios:
Publicar un comentario